U

UCB
UCB

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€29.63B
EV
€30.98B
Shares Outstanding
191.42M
Beta
0.33

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€208.44
P/E 2025E
21.54x
P/Revenue 2025E
4.35x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About UCB SA

gainify

U

UCB SA

UCB

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company’s primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloart...

Sector

Healthcare

Industry

Biotechnology

CEO

Tellier, Jean-Christophe

Employees

9,215

IPO Date

2000-01-04

Headquarters

Allée de la Recherche, 60, Brussels, Brussels, 1070, Belgium

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved